Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.95
+0.0000
Post-market: 1.980.0287+1.47%18:17 EDT
Volume:675.42K
Turnover:1.31M
Market Cap:70.39M
PE:-0.44
High:1.98
Open:1.91
Low:1.90
Close:1.95
Loading ...

Inovio Prices $30 Million Public Offering of Shares, Accompanying Warrants

MT Newswires Live
·
13 Dec 2024

BRIEF-Inovio Announces Pricing Of $30 Million Public Offering

Reuters
·
13 Dec 2024

Inovio Pharmaceuticals Inc Says Pricing of Underwritten Public Offering of 10 Mln Shares

THOMSON REUTERS
·
13 Dec 2024

RH, Broadcom And 3 Stocks To Watch Heading Into Friday

Benzinga
·
13 Dec 2024

Inovio Down 20% After Hours on Planned Stock and Warrant Sale

Dow Jones
·
13 Dec 2024

BUZZ-Inovio Pharma tumbles on planned stock offering

Reuters
·
13 Dec 2024

Inovio Announces Proposed Public Offering

THOMSON REUTERS
·
13 Dec 2024

INOVIO Announces Proposed Public Offering

PR Newswire
·
13 Dec 2024

Inovio Pharmaceuticals Inc. Stock Remains Steady Wednesday, Underperforms Market

Dow Jones
·
12 Dec 2024

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
10 Dec 2024

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
07 Dec 2024

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
05 Dec 2024

Inovio’s INO-3107 shows efficacy in Phase 1/2 RRP trial

TIPRANKS
·
03 Dec 2024

Inovio Pharmaceuticals Inc - No Serious Adverse Events Identified in Retrospective Trial

THOMSON REUTERS
·
03 Dec 2024

New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

THOMSON REUTERS
·
03 Dec 2024

Inovio Pharmaceuticals Inc - New Data to Inform Re-Dosing Strategy for Rrp Treatment

THOMSON REUTERS
·
03 Dec 2024